← Leaderboards
Mary K Danks
St. Jude Children'S Research Hospital
$3,590,066
Attributed
$3,590,066
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $566.9K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$3,590,066 · 4
By mechanism
R01$2,112,582 · 2
P01$1,477,484 · 2
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Philip M Potter$7,971,270
- Michael A Dyer$24,988,379
- Jun Yang$3,072,061
- Xiang Chen$2,994,809
- Dario Campana$6,388,379
Others in their field
Top investigators on “Neuroblastoma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Gregory H Reaman · National Childhood Cancer Foundation$84,462,747
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$58,436,699
- Larry Arthur$30,516,306
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
NeuroblastomaPediatric Neoplasm /CancerCell LineLaboratory MouseXenotransplantationRhabdomyosarcomaCytotoxicityDna TopoisomerasesGene ExpressionEnzyme InhibitorsNeoplastic CellAdenoviridaeTransfection /Expression VectorProdrugsHuman TissueCarboxylic Ester HydrolasesDrug Screening /EvaluationClinical TrialsNeoplasm /Cancer ChemotherapyCamptothecinGalactosamineBone Marrow PurgingDna GyraseDna Replication
Grant awards (14)
Neural Progenitor Cells as Cancer Therapy Vectors$331,343
R01 · FY2007 · CA · contact PI
Selective Therapy of Neuroblastoma$213,341
R01 · FY2007 · CA · contact PI
Neural Progenitor Cells as Cancer Therapy Vectors$331,297
R01 · FY2006 · CA · contact PI
Selective Therapy of Neuroblastoma$219,713
R01 · FY2006 · CA · contact PI
Neural Progenitor Cells as Cancer Therapy Vectors$341,888
R01 · FY2005 · CA
Selective Therapy of Neuroblastoma$225,000
R01 · FY2005 · CA
Selective Therapy of Neuroblastoma$225,000
R01 · FY2004 · CA
Selective Therapy of Neuroblastoma$225,000
R01 · FY2003 · CA
CORE--CELL DISTRIBUTION/CHARACTERIZATION$285,821
P01 · FY2001 · CA
CORE--CELL DISTRIBUTION/CHARACTERIZATION$285,821
P01 · FY2001 · CA
STUDIES OF TOPOISOMERASE I INHIBITORS$285,821
P01 · FY2001 · CA
STUDIES OF TOPOISOMERASE I INHIBITORS$285,821
P01 · FY2001 · CA
STUDIES OF TOPOISOMERASE I INHIBITORS$167,100
P01 · FY2000 · CA
CORE--CELL DISTRIBUTION/CHARACTERIZATION$167,100
P01 · FY2000 · CA